Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-19

Clinical Trial Update: ITCH Trial: Protocol for a Randomized, Double Blind Placebo-controlled Trial [Phase 2, Phase 3]

View source ↗

Summary

Protocol for the ITCH trial detailing a randomized, double-blind, placebo-controlled study planned in Phase 2 and Phase 3 for intracerebral hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kathmandu Medical College and Teaching Hospital | Conditions: Cerebral Hemorrhage | Phase 2, Phase 3 | Status: COMPLETED